Hilton DA - Search Results

1

Hilton DA, Hanemann CO. Hilton DA, et al. Brain Pathol. 2014 Apr;24(3):205-20. doi: 10.1111/bpa.12125. Epub 2014 Feb 25. Brain Pathol. 2014. PMID: 24450866 Free PMC article. Review.

2

The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.

Ammoun S, Schmid MC, Ristic N, Zhou L, Hilton D, Ercolano E, Carroll C, Hanemann CO. Ammoun S, et al. Glia. 2012 Nov;60(11):1721-33. doi: 10.1002/glia.22391. Epub 2012 Jul 20. Glia. 2012. PMID: 22821509

3

Activation of ERK, AKT and JNK signalling pathways in human schwannomas in situ.

Hilton DA, Ristic N, Hanemann CO. Hilton DA, et al. Histopathology. 2009 Dec;55(6):744-9. doi: 10.1111/j.1365-2559.2009.03440.x. Histopathology. 2009. PMID: 19919586

4

Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma.

Maze EA, Agit B, Reeves S, Hilton DA, Parkinson DB, Laraba L, Ercolano E, Kurian KM, Hanemann CO, Belshaw RD, Ammoun S. Maze EA, et al. Among authors: hilton da. Cancer Res. 2022 Jan 15;82(2):235-247. doi: 10.1158/0008-5472.CAN-20-3857. Epub 2021 Dec 1. Cancer Res. 2022. PMID: 34853069

5

Cellular prion protein (PrP^C) in the development of Merlin-deficient tumours.

Provenzano L, Ryan Y, Hilton DA, Lyons-Rimmer J, Dave F, Maze EA, Adams CL, Rigby-Jones R, Ammoun S, Hanemann CO. Provenzano L, et al. Among authors: hilton da. Oncogene. 2017 Nov 2;36(44):6132-6142. doi: 10.1038/onc.2017.200. Epub 2017 Jul 10. Oncogene. 2017. PMID: 28692055

6

The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.

Zhou L, Lyons-Rimmer J, Ammoun S, Müller J, Lasonder E, Sharma V, Ercolano E, Hilton D, Taiwo I, Barczyk M, Hanemann CO. Zhou L, et al. Oncogene. 2016 Jun 30;35(26):3443-53. doi: 10.1038/onc.2015.404. Epub 2015 Nov 9. Oncogene. 2016. PMID: 26549023 Free PMC article.

7

Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.

Ammoun S, Ristic N, Matthies C, Hilton DA, Hanemann CO. Ammoun S, et al. Among authors: hilton da. Neurobiol Dis. 2010 Jan;37(1):141-6. doi: 10.1016/j.nbd.2009.09.017. Epub 2009 Oct 3. Neurobiol Dis. 2010. PMID: 19804833

8

Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis.

Zhang H, Hilton DA, Hanemann CO, Zajicek J. Zhang H, et al. Among authors: hilton da. Brain Pathol. 2011 Sep;21(5):544-57. doi: 10.1111/j.1750-3639.2011.00477.x. Epub 2011 Feb 22. Brain Pathol. 2011. PMID: 21251115 Free PMC article.

9

The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.

Ammoun S, Schmid MC, Zhou L, Hilton DA, Barczyk M, Hanemann CO. Ammoun S, et al. Among authors: hilton da. Mol Oncol. 2015 Jan;9(1):236-48. doi: 10.1016/j.molonc.2014.08.005. Epub 2014 Aug 27. Mol Oncol. 2015. PMID: 25217104 Free PMC article.

10

Activation of multiple growth factor signalling pathways is frequent in meningiomas.

Hilton DA, Shivane A, Kirk L, Bassiri K, Enki DG, Hanemann CO. Hilton DA, et al. Neuropathology. 2016 Jun;36(3):250-61. doi: 10.1111/neup.12266. Epub 2015 Nov 10. Neuropathology. 2016. PMID: 26554033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters